Presentations from the InfoDay on Health, demographic change and wellbeing – 8 July 2016

  Health, demographic change and well-being’ – Work Programme 2016-2017 - Introduction
  Cross-cutting items: social sciences and humanities, gender, ethics, international cooperation, communication
  Rules of participation. Key legal and financial questions
  Clinical trials
  EU Life Science Infrastructures - DG RTD
  ◾EU Life Science Infrastructures - ANR
  ◾Funding opportunities for businesses - DG RTD
  ◾Funding opportunities for businesses - PMD Solutions
  ◾Funding opportunities for businesses - EUROSTARS
  ◾Funding opportunities for businesses : Digital Innovation for Active and Healthy Ageing
  ◾ICT for Health, Well-being and Active & Healthy Ageing: Overview of the in-silico topics PM-16 and PM-17
  ◾ICT for Health, Well-being and Active & Healthy Ageing: Overview of PM-19 PPI for uptake of standards for the exchange of digitalised healthcare records
  ◾Infectious Diseases
  ◾Infectious Diseases: The Innovative Medicines Initiative: Building new models of collaborative research across Europe
  ◾Infectious Diseases: EU Finance for Innovators – Supporting innovation
  ◾Infectious Diseases: Joint Programming Initiative on Antimicrobial Resistance
  ◾Infectious Diseases: EDCTP2 – Opportunities for clinical research on poverty-related diseases in sub-Saharan Africa
  ◾Personalised medicine and non-communicable diseases : Personalised Medicine and Rare Diseases
  ◾Personalised medicine and non-communicable diseases: Developing new international collaborations and writing excellent proposals for funding
  ◾Personalised medicine and non-communicable diseases : Tips for ending up with a successful H2020 proposal: Experience sharing from the UM Cure 2020 project
  ◾Personalised medicine and non-communicable diseases: Non communicable diseases
  ◾Personalised medicine and non-communicable diseases : European Regulatory Science on Tobacco – Policy implementation to reduce lung disease
  ◾Regenerative Medicine and Advanced Therapies
  ◾Regenerative Medicine and Advanced Therapies: ATMP Experiences from The ONE Study
  ◾Regenerative Medicine and Advanced Therapies : Mesenchymal stem cell based therapy: challenge for a new biomedicine
Jump to page content